SCHEMBL31089708

SCHEMBL31089708

COc1cccc(/C=N/Nc2cc(N3CCOCC3)n3nc(-c4ccncc4)nc3n2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIKFYVE Q9Y2I7 4/20 0.61
MAPT P10636 9/20 0.45
POLB P06746 2/20 0.45
ATM Q13315 1/20 0.45
KDM4E B2RXH2 7/20 0.43
LMNA P02545 3/20 0.43
ALDH1A1 P00352 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 2/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
FES P07332 1/20 0.40
FER P16591 1/20 0.40
TYK2 P29597 1/20 0.40
FRK P42685 1/20 0.40
SYK P43405 1/20 0.40
CAMK1D Q8IU85 1/20 0.40
IRAK4 Q9NWZ3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20511300 1.00 PIKFYVE (0.61) PIKFYVEMAPTPOLBATMKDM4E
SCHEMBL20511305 1.00 PIKFYVE (0.61) PIKFYVEMAPTPOLBATMKDM4E
SCHEMBL20511292 0.92 PIKFYVE (0.55) PIKFYVEMAPTPOLBATMKDM4E
SCHEMBL20511297 0.92 PIKFYVE (0.55) PIKFYVEMAPTPOLBATMKDM4E
SCHEMBL31089581 0.92 PIKFYVE (0.55) PIKFYVEMAPTPOLBATMKDM4E
SCHEMBL31089726 0.89 PIKFYVE (0.76) PIKFYVEMAPTATMKDM4ELMNA
SCHEMBL20511322 0.89 PIKFYVE (0.76) PIKFYVEMAPTATMKDM4ELMNA
SCHEMBL20511324 0.89 PIKFYVE (0.76) PIKFYVEMAPTATMKDM4ELMNA
SCHEMBL20511365 0.87 PIKFYVE (0.61) PIKFYVEMAPTATMKDM4ELMNA
SCHEMBL20511360 0.87 PIKFYVE (0.61) PIKFYVEMAPTATMKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240294536-A1 FUSED TRIAZOLO-PYRIMIDINE COMPOUNDS HAVING USEFUL PHARMACEUTICAL APPLICATION PIKSCI INC. (CA) 2024-09-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294536-A1 FUSED TRIAZOLO-PYRIMIDINE COMPOUNDS HAVING USEFUL PHARMACEUTICAL APPLICATION PIKFYVE, PIP4K2B, PIK3CA PIKFYVE 1/4885MAPT 3840/4885POLB 1258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.